Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.1K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.1K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

279
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
279
Drug Regulation01:25

Drug Regulation

2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Drug Development.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Evidence For Cannabidiol Modulation of Serotonergic Transmission in a Model of Osteoarthritis via <i>in vivo</i> PET Imaging and Behavioral Assessment.

International journal of innovative research in medical science·2023
Same author

RS12574989 and haplotype associated with α/β-chain imbalance and population HbA2 reduction.

BMC medical genomics·2022
Same author

Cooperative ETM-Based Adaptive Neural Network Tracking Control for Nonlinear Pure-Feedback MASs: A Special-Shaped Laplacian Matrix Method.

IEEE transactions on neural networks and learning systems·2022
Same author

Effect of femoral head necrosis cystic area on femoral head collapse and stress distribution in femoral head: A clinical and finite element study.

Open medicine (Warsaw, Poland)·2022
Same author

Novel optimal trajectory tracking for nonlinear affine systems with an advanced critic learning structure.

Neural networks : the official journal of the International Neural Network Society·2022

相关实验视频

Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K

药物开发 药物开发

Fernando Goni1, Ding Wang1, Jianina Suazo1

  • 1NYU Grossman School of Medicine, New York, NY, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
PubMed
概括

针对粉样β寡合体的两种IgM抗体,GW-23B7和WG-3D7,在阿尔茨海默病 (AD) 鼠标模型中显示出显著的认知救援. 这些AβComAbs在不引起炎症或微出血的情况下降低了Aβ病理,这表明人类安全临床试验的潜力.

更多相关视频

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

相关实验视频

Last Updated: Jan 7, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

10.1K
In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing
08:04

In Vitro Three-Dimensional Sprouting Assay of Angiogenesis Using Mouse Embryonic Stem Cells for Vascular Disease Modeling and Drug Testing

Published on: May 11, 2021

3.3K
Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells
05:45

Developmental Toxicity Assay Based on Real-Time Monitoring of Fibroblast Growth Factor Signal Disruption in Human Induced Pluripotent Stem Cells

Published on: October 10, 2025

451

科学领域:

  • 神经科学是一个神经科学.
  • 免疫学 免疫学 免疫学
  • 生物化学 生物化学

背景情况:

  • 阿尔茨海默病 (AD) 病理学涉及具有特定β-片次要结构的粉样β (Aβ) 寡合体.
  • 之前的研究表明,针对这些结构的IgM单克隆抗体 (GW-23B7) 在AD小鼠模型中拯救了认知,没有任何不良影响.
  • 这项研究调查了两个这样的抗体,GW-23B7和WG-3D7,在脑粉样血管病变 (CAA) 模型中,具有不同的人类阿波利波蛋白E (apoE) 全型.

研究的目的:

  • 评估两种针对Aβ寡合体的IgM抗体 (GW-23B7和WG-3D7) 的治疗疗效和安全性.
  • 在表达人类apoE异型 (E2,E3,E4) 的脑粉样血管病变 (CAA) 的转基因小鼠模型中评估抗体性能.
  • 为了确定这些抗体是否可以减少Aβ病理,并改善认知功能,而不会引起炎症或微型出血等不良影响.

主要方法:

  • 临床前试验涉及11个月大的TgSwDI小鼠 (具有apoE2,E3或E4),每周接受两个月的GW-23B7或WG-3D7 (100微克/动物) 治疗.
  • 进行了行为和认知测试 (例如,巴恩斯迷宫) 和运动运动评估.
  • 脑组织分析包括免疫组织化学 (Iba1,GFAP,CD-45) 和生化分析 (ELISA) 来量化Aβ病理和质激活.

主要成果:

  • 无论GW-23B7和WG-3D7都穿透了血脑屏障 (BBB) 并与大脑血管系统相互作用,而不会引起微出血 (普鲁士蓝色染色).
  • 与对照组相比,接受治疗的小鼠表现出显著的认知改善,与减少可溶性聚合Aβ和降低血管/副细胞Aβ沉积相关.
  • 免疫组织化学检测显示,在治疗组中,激活的质细胞 (Iba1,GFAP,CD-45) 减少;两种抗体之间观察到微小的差异.

结论:

  • 通过Aβ序列独立的机制,局部给药的向Aβ寡合体的IgM抗体 (GW-23B7,WG-3D7) 有效地减少可溶性和沉积的Aβ病理.
  • 这些抗体避免由抗体依赖细胞介导的细胞毒性 (ADCC) 诱导的微出血或炎症,无论人类的apoE全型.
  • 临床前数据支持将这些IgM抗体安全转化为人类AD临床试验,其ARIA或自身免疫并发症风险较低.